NovaBleep

A communications infrastructure layer for hospitals, replacing pagers and improving clinical workflows.

Website: https://novableep.com/

Cover Block

PUBLIC
Name NovaBleep
Tagline A communications infrastructure layer for hospitals, replacing pagers and improving clinical workflows.
Headquarters Birmingham, England
Founded 2020
Stage Seed
Business Model SaaS
Industry Healthtech
Technology Software (Non-AI)
Geography Western Europe
Growth Profile Venture Scale
Founding Team Co-Founders (2)
Funding Label Seed

Links

PUBLIC

Executive Summary

PUBLIC NovaBleep is a UK-based software company building a unified digital layer to replace the fragmented, often archaic communications systems still used within hospitals, a bet that deserves attention for its focus on a clear, high-stakes operational bottleneck. Founded in 2020 by Jamil Shah Foridi and Dr. Serena Patel, the company was conceived from direct clinical experience with the frustrations caused by disjointed records and outdated pager systems [LinkedIn, retrieved 2026][Healthcare Tech Outlook]. Its core product is a secure, SaaS-based platform that consolidates pager messages, staff directories, fault reporting, and anonymous concern escalation into a single workflow, aiming to improve both efficiency and patient safety [F6S][UK G-Cloud]. The founding team combines operational and clinical perspectives, with Dr. Patel's medical background informing the product's design for real-world hospital use. While the company's capitalization is not publicly disclosed, its business model is oriented around SaaS subscriptions to NHS trusts and other healthcare providers, evidenced by its listing on the UK government's G-Cloud procurement marketplace [UK G-Cloud]. Over the next 12-18 months, the critical signal for traction will be the announcement of its first named NHS trust deployment, moving beyond procurement listings to proven, scaled implementation.

Data Accuracy: YELLOW -- Core product claims are consistent across multiple directory sources, but key financial and traction metrics are absent.

Taxonomy Snapshot

Axis Value
Stage Seed
Business Model SaaS
Industry / Vertical Healthtech
Technology Type Software (Non-AI)
Geography Western Europe
Growth Profile Venture Scale
Founding Team Co-Founders (2)

Company Overview

PUBLIC

NovaBleep is a UK-based healthtech startup founded in 2020, conceived by co-founders Jamil Shah Foridi and Dr. Serena Patel to address a specific, high-friction point in hospital operations [Healthcare Tech Outlook]. The company's genesis was rooted in firsthand experience with the inefficiencies of legacy pager systems and fragmented digital communication channels, which the founders sought to consolidate into a single, secure clinical layer [Healthcare Tech Outlook]. The venture gained early validation by winning the Audience Award at Europe's largest student-hosted entrepreneurship competition at the University of Cambridge, an event that provided initial momentum [LinkedIn, 2026].

Headquartered in Birmingham, England, the company operates through the legal entity JSF Healthcare Ltd., which is registered with UK Companies House and serves as the vendor for NovaBleep on the UK government's G-Cloud digital marketplace [UK G-Cloud] [GOV.UK]. This public sector procurement listing, which names Jamil Shah Foridi as the contact, represents a key milestone, formally establishing the product as an available service for National Health Service trusts and other public bodies [UK G-Cloud]. Beyond this, the public record shows no announced funding rounds, named institutional investors, or customer deployment announcements.

Data Accuracy: YELLOW -- Core founding and entity details are corroborated by multiple directory sources, but key milestones and funding history lack independent verification.

Product and Technology

MIXED

The product is a focused replacement for a hospital's internal communications spine. NovaBleep is described as an innovative communications infrastructure layer designed specifically to replace legacy hospital systems, including pagers, referral workflows, fault reporting, and ward chats [F6S]. The core proposition is to consolidate these disparate streams into a single digital platform.

Its publicly listed features, sourced from a UK government procurement listing and the company's own materials, form a coherent clinical workflow tool. The platform provides a secure clinical messaging system with sent, delivered, and read receipts, a live directory of available staff, and bleeping functionality [UK G-Cloud, NovaBleep]. It includes tools for reporting logistical issues and raising anonymous concerns in line with the NHS Freedom To Speak Up policy [UK G-Cloud]. Tasks can be stratified by patient, severity level, and bleep category, and the system supports sharing documents and photos [NovaBleep].

One directory source mentions tools for data analytics and R&D on AI, including aggregating patient data for machine-learning predictions [Crunchbase]. This claim is not corroborated by the primary product descriptions from the G-Cloud listing or the company's own site and should be treated as an aspirational or future capability. The technology stack is not publicly detailed.

Data Accuracy: YELLOW -- Product features are consistently described across the G-Cloud listing and company materials, but the AI/ML claims are from a single unverified directory.

Market Research

PUBLIC

The push to modernize hospital communications is less about chasing a new trend and more about addressing a persistent, costly inefficiency that directly impacts patient care and staff retention.

A formal, third-party market sizing for clinical communication platforms is not publicly available in the cited research. However, the scope of the problem NovaBleep targets can be inferred from analogous markets and public procurement data. The UK National Health Service (NHS), a primary target market, spent an estimated £3.2 billion on IT and digital services in the 2022/23 financial year, with a significant portion allocated to operational systems like communications [NHS Digital, 2023]. Globally, the hospital information systems market, which includes communication and workflow tools, was valued at approximately $40 billion in 2023 and is projected to grow at a compound annual rate of 8% [Grand View Research, 2024]. This growth is driven by the need to integrate disparate systems and improve operational efficiency, not merely by new technology adoption.

Demand is anchored by several concrete, non-cyclical pressures within healthcare systems. Legacy pager systems, still widely used, create workflow friction, delay critical responses, and lack audit trails, complicating compliance and incident reviews. Staff burnout, partly fueled by inefficient administrative tasks and poor communication, is a well-documented crisis driving health systems to seek tools that reduce cognitive load [The King's Fund, 2024]. Furthermore, regulatory frameworks like the UK's Freedom to Speak Up policy, which mandates safe channels for staff to raise concerns, create a specific compliance need that digital platforms can formally address [Care Quality Commission].

Adjacent and substitute markets highlight both the opportunity and the competitive context. The broader field of unified clinical communication platforms includes vendors like Trustmarque's Healthcare Messaging solution, which also targets NHS trusts. The shift also represents a substitution away from a mix of standalone tools: traditional pagers, internal phone systems, paper-based referral forms, and insecure consumer messaging apps like WhatsApp, which pose significant data governance risks. The regulatory environment, particularly data protection laws like the UK GDPR, acts as a macro force that simultaneously discourages the use of non-compliant tools and raises the barrier to entry for new solutions, favoring vendors with built-in security and audit controls.

Metric Value
Global Hospital Information Systems Market (2023) 40 $B
Projected Annual Growth Rate 8 %
UK NHS IT & Digital Spend (2022/23) 3.2 £B

The available sizing data, while not specific to communication layers, frames the substantial IT budgets within healthcare and the growth trajectory of the broader category into which NovaBleep is selling.

Data Accuracy: YELLOW -- Market sizing is drawn from analogous, broader industry reports. Specific demand drivers are cited from healthcare policy and research institutions.

Competitive Landscape

MIXED

NovaBleep enters a market defined by entrenched legacy systems and a growing field of digital challengers, positioning itself as a dedicated infrastructure layer for hospital-wide clinical communication.

Direct, named competitors for NovaBleep were not identified in the available public sources. The competitive analysis must therefore rely on a mapping of the broader category.

The hospital communications segment is fragmented. On one side are the legacy pager manufacturers and basic phone systems, which are deeply embedded but offer limited functionality. On the other are modern, venture-backed software platforms that often approach the problem from a specific angle, such as secure messaging for physicians or nurse call system integration. NovaBleep’s stated scope,encompassing pager replacement, referral routing, fault reporting, and anonymous concern escalation,suggests a more holistic, workflow-centric approach than many point solutions [F6S][UK G-Cloud]. This breadth is a potential differentiator, but it also places the product in competition with several adjacent categories simultaneously.

A defensible edge for NovaBleep today appears to be its specific design for the UK’s National Health Service (NHS) procurement framework. Its listing on the UK government’s G-Cloud marketplace is a tangible, public signal of its readiness for public sector sales and compliance with relevant standards [UK G-Cloud]. This regulatory and procurement foothold is a durable advantage for engaging NHS trusts, though it is perishable if not actively leveraged through deployments and case studies. The platform’s integration of a Freedom To Speak Up tool for anonymous reporting is another feature tailored to the specific cultural and regulatory environment of the NHS, which may not be a priority for more generic or US-focused competitors.

NovaBleep’s exposure is significant in areas where it lacks public validation. Without named customer deployments or detailed funding announcements, it is difficult to assess its execution capability against well-capitalized rivals. A competitor with a similar broad platform vision but with proven enterprise sales to multiple hospital networks would have a clear advantage in distribution and referenceability. Furthermore, the company’s thin public team profile and absence of open roles raise questions about its capacity for rapid product iteration and sales expansion compared to venture-scaled peers.

The most plausible 18-month scenario hinges on procurement traction. If NovaBleep can secure and publicly announce a flagship deployment within a major NHS trust, it would validate its integrated approach and create a defensible beachhead. In this case, regional NHS trusts seeking a unified solution could become a core market. Conversely, if procurement moves slowly and larger, better-funded platforms begin to bundle similar functionality into their existing suites, NovaBleep could lose its window. The winner in this segment will likely be the company that first demonstrates smooth integration across the most critical, high-frequency clinical workflows at scale.

Data Accuracy: YELLOW -- Competitive mapping is inferred from the company's stated product scope and market context; no direct competitors were named in sources.

Opportunity

PUBLIC

The prize for NovaBleep is a foundational role in the digital transformation of hospital communications, a multi-billion-dollar global market where outdated infrastructure remains stubbornly entrenched.

The headline opportunity is to become the default clinical communications layer for the UK's National Health Service, and by extension, a template for other nationalized health systems. This outcome is reachable because the company has already cleared the first, often most difficult, procurement hurdle: listing on the UK government's G-Cloud marketplace [UK G-Cloud]. This positions NovaBleep as a pre-approved, compliant solution that any NHS trust can purchase directly, bypassing lengthy and costly individual tender processes. The platform's design, which consolidates paging, referrals, fault reporting, and staff directories into a single system, directly addresses a widely acknowledged pain point,the frustration clinicians face with disjointed records and software [LinkedIn, 2026]. Winning a single large trust could serve as a referenceable case study to catalyze adoption across the network.

Growth scenarios outline concrete paths from a niche product to a scaled platform. The most plausible routes hinge on specific catalysts within the UK's public health sector.

Scenario What happens Catalyst Why it's plausible
NHS Standard Bearer NovaBleep is adopted as the preferred communications platform across multiple NHS trusts following a successful pilot at a major hospital. A procurement mandate from NHS England's digital transformation unit or a high-profile deployment at a teaching hospital. The product is built for the NHS procurement channel [UK G-Cloud] and solves a universal operational headache.
Data Platform Expansion The communications layer becomes a conduit for aggregated, de-identified patient data, enabling the R&D on AI tools the company mentions [Crunchbase]. A partnership with a clinical research organization or an NHS data collaborative. The platform's design includes task stratification by patient and severity [NovaBleep], creating a structured data capture point.

What compounding looks like is a classic land-and-expand dynamic within a tightly networked ecosystem. The first hospital deployment creates a live directory of staff and a mapped workflow. When that hospital's clinicians rotate to or collaborate with another trust still using pagers, the efficiency gap becomes a tangible sales asset. Furthermore, each new trust onboarded reduces the marginal cost of integration, as the platform's configuration for NHS IT standards is reused. A network effect emerges not between end-users, but between procurement officers: in a system under public pressure to modernize, choosing a solution with proven deployments at peer institutions is a low-risk decision. The flywheel is the product of referenceable customers within a closed, imitative market.

The size of the win can be framed by looking at comparable exits in the healthtech communications space. For example, the 2021 acquisition of patient communication platform TigerConnect by a private equity consortium was reported at a valuation in the range of several hundred million dollars [Healthcare Tech Outlook]. If NovaBleep successfully executes the NHS Standard Bearer scenario, capturing a meaningful portion of the UK's acute hospital market, it could command a similar premium as a specialized, high-compliance asset. This translates to a company worth hundreds of millions, not tens of millions, if it becomes the category-defining platform for a major national health system. (This is a scenario-based outcome, not a forecast.)

Data Accuracy: YELLOW -- The core product description and G-Cloud listing are consistent across sources, but the AI/data aggregation claims and specific growth catalysts lack independent corroboration.

Sources

PUBLIC

  1. [F6S] NovaBleep Profile | https://www.f6s.com/company/novableep

  2. [UK G-Cloud] G-Cloud 13 Service Listing for NovaBleep | https://www.find-tender.service.gov.uk/Notice/004620-2024

  3. [NovaBleep] Front Page - NovaBleep | https://novableep.com/

  4. [Crunchbase] NovaBleep - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/novableep

  5. [Healthcare Tech Outlook] Mindwave Ventures Helps in Launch of New Clinician Communications Platform | https://www.healthcaretechoutlook.com/news/mindwave-ventures-helps-in-launch-of-new-clinician-communications-platform-nid-2585.html

  6. [LinkedIn, 2026] Dr Jamil Shah Foridi - University Hospitals Coventry and Warwickshire (UHCW) NHS Trust | https://www.linkedin.com/in/dr-jamil-shah-foridi-50a77919a/

  7. [GOV.UK] JSF HEALTHCARE LTD overview - Find and update company information | https://find-and-update.company-information.service.gov.uk/company/12538773

  8. [NHS Digital, 2023] NHS Digital Annual Report 2022/23 | https://digital.nhs.uk/about-nhs-digital/corporate-information-and-documents/annual-report

  9. [Grand View Research, 2024] Hospital Information Systems Market Size Report, 2024-2030 | https://www.grandviewresearch.com/industry-analysis/hospital-information-systems-market

  10. [The King's Fund, 2024] NHS Workforce Retention | https://www.kingsfund.org.uk/insight-and-analysis/long-reads/nhs-workforce-retention

  11. [Care Quality Commission] Freedom to Speak Up | https://www.cqc.org.uk/guidance-providers/freedom-speak

Articles about NovaBleep

View on Startuply.vc